Who is sponsoring NCT01784263?

NCT01784263 is sponsored by University of California, Los Angeles.

What drugs are being tested in NCT01784263?

Interventions in NCT01784263: Individual Cognitive Behavioral Therapy, Standard Community Treatment.

What condition does NCT01784263 study?

NCT01784263 studies Autism Spectrum Disorder.

Is NCT01784263 still recruiting?

NCT01784263 is currently completed. Last updated 7 September 2018.

Last reviewed 2018-09-07 · How we verify

NCT01784263: SEBASTIEN

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Schema, Emotion, and Behavior Therapy for Children

Completed NA Last updated 7 September 2018

What this trial tests

NA trial testing Individual Cognitive Behavioral Therapy in Autism Spectrum Disorder in 70 participants. Completed in 1 September 2017.

Timeline

1 March 2012

Primary endpoint
1 February 2017

1 September 2017

Quick facts

Lead sponsor	University of California, Los Angeles
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	70
Start date	1 March 2012
Primary completion	1 February 2017
Estimated completion	1 September 2017
Sites	1 location across United States

Drugs / interventions tested

Individual Cognitive Behavioral Therapy
Standard Community Treatment

Conditions studied

Autism Spectrum Disorder — all drugs for Autism Spectrum Disorder →

Sponsor

University of California, Los Angeles

Who can join

Adults 9 to 13, any sex, with Autism Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is a randomized controlled trial to examine the efficacy of individual cognitive behavioral therapy (CBT) relative to a standard community treatment, in youngsters with autism spectrum disorder (ASD). The individual CBT program has been tailored over the last five years to the clinical needs of high-functioning youth with ASD.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Modular cognitive behavioral therapy for autism-related symptoms in children: A randomized controlled trial.
Wood JJ, Sze Wood K, Chuen Cho A, Rosenau KA, et al · · 2021 · cited 20× · PMID 33705167 · DOI 10.1037/ccp0000621
Effectiveness of social skills training interventions for children with autism spectrum disorder: A systematic review and meta-analysis.
Alahmari FS, Alhabbad AA, Alshamrani HA, Almuqbil MA. · · 2025 · cited 2× · PMID 40096975 · DOI 10.15537/smj.2025.46.3.20240788

Verify or expand the search:

Other recruiting trials for Autism Spectrum Disorder

Currently open trials in the same condition.

NCT07324057 — The Effects of Preoperative Intranasal Administration of Dexmedetomidine and Esketamine on Negative Postoperative Behavi · NA · recruiting
NCT07493096 — Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disor · recruiting
NCT07505290 — Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial f · NA · active not recruiting
NCT07524192 — A Self-Instructional Online Program for Early Childhood and Elementary Teachers Supporting Autistic Children and Childre · NA · recruiting
NCT07432776 — Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design · EARLY_PHASE1 · recruiting

Other University of California, Los Angeles trials

Trials by the same sponsor.

NCT04846517 — rTMS for Aneroxia Nervosa in Youth · NA · not yet recruiting
NCT06701760 — Sodium Lactate in Severe TBI · Phase 2 · not yet recruiting
NCT04996667 — Effect of iNO in Patients With Submassive and Massive PE · Phase 2 · withdrawn
NCT05067387 — Evaluation of Oral THC and CBD in Men and Women · Phase 1 · not yet recruiting
NCT07534696 — Evaluation of Non-Invasive Pelvic Floor Neuromuscular Stimulation for Urinary Incontinence After Prostatectomy · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01784263 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, Los Angeles
Last refreshed: 7 September 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01784263.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing